Cover Image
市場調查報告書

慢性肝疾病:全球臨床實驗趨勢

Chronic Liver Disease Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 196100
出版日期 內容資訊 英文 106 Pages
訂單完成後即時交付
價格
Back to Top
慢性肝疾病:全球臨床實驗趨勢 Chronic Liver Disease Global Clinical Trials Review, H1, 2017
出版日期: 2017年06月30日 內容資訊: 英文 106 Pages
簡介

本報告提供慢性肝疾病的治療藥的相關臨床實驗資料調查,提供您臨床實驗數及受驗人數,各階段、Phase別狀況,有潛力的企業,開發中的治療藥資訊,臨床實驗簡介等彙整資料。

簡介

  • 慢性肝疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上慢性肝疾病的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上慢性肝疾病的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

慢性肝疾病治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Puma Biotechnology, Inc.
    • PharmaKing Co., Ltd.
    • Abbott Laboratories
    • GeneCare Research Institute Co.,Ltd.
    • Fresenius SE & Co. KGaA
    • F. Hoffmann-La Roche Ltd.
    • Exalenz Bioscience Ltd.
    • Eisai
    • Celltrion Pharm Inc.
    • Bristol-Myers Squibb Company
  • 有代表性的研究機關·醫院臨床實驗概要
    • Institute of Liver and Biliary Sciences
    • 302 Military Hospital of China
    • Amrita Institute of Medical Sciences and Research Centre
    • Azienda Ospedaliera di Padova
    • Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
    • Baermed
    • Bangabandhu Sheikh Mujib Medical University
    • Birmingham Children's Hospital NHS Trust
    • Coordinacion de Investigacion en Salud
    • Daejeon University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4298CTIDB

GlobalData's clinical trial report, "Chronic Liver Disease Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Liver Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Chronic Liver Disease to Gastrointestinal Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Chronic Liver Disease to Gastrointestinal Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 23
  • Clinical Trials in E7 Countries by Trial Status 24
  • Clinical Trials by Phase 25
  • In Progress Trials by Phase 26
  • Clinical Trials by Trial Status 27
  • Clinical Trials by End Point Status 29
  • Subjects Recruited Over a Period of Time 30
  • Clinical Trials by Sponsor Type 31
  • Prominent Sponsors 32
  • Top Companies Participating in Chronic Liver Disease Therapeutics Clinical Trials 34
  • Prominent Drugs 36
  • Clinical Trial Profile Snapshots 37

Appendix 104

  • Abbreviations 104
  • Definitions 104
  • Research Methodology 105
  • Secondary Research 105
  • About GlobalData 106
  • Contact Us 106
  • Source 106

List of Tables

List of Tables

  • Chronic Liver Disease Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Chronic Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Chronic Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Chronic Liver Disease Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Chronic Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Chronic Liver Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Chronic Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 17
  • Chronic Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Chronic Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Proportion of Chronic Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 22
  • Chronic Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • Chronic Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials by Phase, 2017* 25
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
  • Chronic Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 31
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36

List of Figures

List of Figures

  • Chronic Liver Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Chronic Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Chronic Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Chronic Liver Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Chronic Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Chronic Liver Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
  • Proportion of Chronic Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 16
  • Chronic Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Chronic Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Chronic Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 21
  • Chronic Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • Chronic Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26
  • Chronic Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
  • Chronic Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 31
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
  • Chronic Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
  • GlobalData Methodology 105
Back to Top